Literature DB >> 11479945

[Analyses of the factors affecting the occurrence of polypronuclear embryos in in-vitro fertilization and embryo transfer].

F Jin1, Y Shi, F Zhou.   

Abstract

OBJECTIVE: To investigate the factors affecting the occurrences of the polypronuclear embryos in in-vitro fertilization and embryo transfer (IVF-ET).
METHODS: The data from 145 IVF-ET cycles and 1,168 oocytes were analyzed by logistic regression for multiple factors. The influences of the couple's age, the superovulation stimulation protocols, the number of the follicles punctured and the oocytes obtained, the preinseminational interval, the quality and quantity of seminal and inseminational sperms, and the oocyte fertilization ratio on the incidences of the polypronuclear embryos from the matured, and immature oocytes were examined respectively.
RESULTS: The incidence of the polypronuclear embryos from matured oocytes was significantly negatively correlated with the women age and the number of the follicles punctured, and the incidence from immature oocytes was significantly positively correlated with the density of sperms at grade a and b and the oocyte fertilization ratio.
CONCLUSIONS: The woman's age and the number of follicles are the main factors which influence the occurrence of polypronuclear embryos from matured oocytes, while the density of the seminal sperm with high motility and the fertilization ratio play important roles in the occurrence of polypronuclear embryos in immature oocytes. Stimulating greater number of follicles might be benefit for the reduction of occurrence of polypronuclear embryos.

Entities:  

Mesh:

Year:  1999        PMID: 11479945

Source DB:  PubMed          Journal:  Zhonghua Fu Chan Ke Za Zhi        ISSN: 0529-567X


  1 in total

1.  Three pro-nuclei (3PN) incidence factors and clinical outcomes: a retrospective study from the fresh embryo transfer of in vitro fertilization with donor sperm (IVF-D).

Authors:  Mingzhao Li; Wanqiu Zhao; Xia Xue; Silin Zhang; Wenhao Shi; Juanzi Shi
Journal:  Int J Clin Exp Med       Date:  2015-08-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.